摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(p-Chlorophenylmethyl)-2(1H)-benzimidazolone | 131705-70-9

中文名称
——
中文别名
——
英文名称
N-(p-Chlorophenylmethyl)-2(1H)-benzimidazolone
英文别名
3-[(4-chlorophenyl)methyl]-1H-benzimidazol-2-one
N-(p-Chlorophenylmethyl)-2(1H)-benzimidazolone化学式
CAS
131705-70-9
化学式
C14H11ClN2O
mdl
MFCD03673081
分子量
258.707
InChiKey
KAVIELWLXMKZMP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.344±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    1

SDS

SDS:a26999aca2d40b91a98862787157f2d7
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists
    摘要:
    Melanin concentrating hormone (MCH) is an important mediator of energy homeostasis and plays role in several disorders such as obesity, stress, depression and anxiety. The synthesis and biological evaluation of novel benzimidazole derivatives as MCHR1 antagonists are described. The in vivo proof of principle for weight loss with a lead compound from this series is exemplified. (c) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.086
  • 作为产物:
    描述:
    potassium carbonate 作用下, 以 乙醇 为溶剂, 反应 6.0h, 生成 N-(p-Chlorophenylmethyl)-2(1H)-benzimidazolone
    参考文献:
    名称:
    Use of polymer supported thiophenol for the synthesis and purification of a benzimidazol-2-one library
    摘要:
    An efficient solution phase synthesis of substituted benzimidazol-2-ones is described. Polymer-supported thiophenol is used to remove excess alkylating agents. A library of 24 mono- and di-substituted benzimidazol-2-ones has been prepared in 60-99% yield and 65-99% purity. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4039(00)00185-4
点击查看最新优质反应信息

文献信息

  • Direct Synthesis of N-Monosubstituted Benzimidazol-2-ones via Ph3P–I2-Mediated Reaction of Hydroxamic Acids
    作者:Wong Phakhodee、Nittaya Wiriya、Dolnapa Yamano、Surat Hongsibsong、Mookda Pattarawarapan
    DOI:10.1055/s-0040-1719897
    日期:2022.9
    A facile approach for the synthesis of benzimidazolones via a Ph3P–I2 promoted reaction of hydroxamic acids is reported. Upon Lossen-type rearrangement of the O-activated hydroxamic acids, the in situ generated isocyanates undergo an intramolecular attack by ortho N-nucleophiles producing the cyclized products in good yields under mild conditions. The method allows the direct preparation of a single
    报道了一种通过Ph 3 P-I 2促进的异羟肟酸反应合成苯并咪唑酮的简便方法。在 O 活化异羟肟酸的 Lossen 型重排后,原位生成的异氰酸酯受到邻N-亲核试剂的分子内攻击,在温和条件下以良好的收率产生环化产物。该方法允许使用易于获得的起始材料和具有广泛底物范围的低成本试剂直接制备 N-单取代衍生物的单一区域异构体。
  • PIPERIDINES
    申请人:Gross F. Michael
    公开号:US20080058376A1
    公开(公告)日:2008-03-06
    Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-dependent sodium channels. More particularly, the invention provides substituted piperidines, and compositions containing these compounds. Also provided are methods using the compounds of the invention for the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrance of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a channel that includes a PN3 subunit.
    本发明提供了用于通过抑制电压依赖性钠通道中的钠离子通量来治疗疾病的化合物、组合物和方法。更具体地,本发明提供了取代哌啶的化合物和含有这些化合物的组合物。还提供了使用本发明的化合物治疗中枢或外周神经系统障碍,特别是疼痛和慢性疼痛的方法,通过阻断与所述病症的发作或复发相关的钠通道。本发明的化合物、组合物和方法特别适用于通过抑制包括PN3亚单位的通道中的离子通量来治疗神经病理性或炎症性疼痛。
  • Caroti; Ceccotti; Da Settimo, Il Farmaco, 1989, vol. 44, # 3, p. 227 - 255
    作者:Caroti、Ceccotti、Da Settimo、Primofiore、Franzone、Reboani、Cravanzola
    DOI:——
    日期:——
  • Kus; Goker; Ayhan, Il Farmaco, 1996, vol. 51, # 6, p. 413 - 417
    作者:Kus、Goker、Ayhan、Ertan、Altanlar、Akin
    DOI:——
    日期:——
  • CAROTI, P.;CECCOTTI, C.;DA, SETTIMO F.;PRIMOFIORE, G.;FRANZONE, J. S.;REB+, FARMACO, 44,(1989) N, C. 227-255
    作者:CAROTI, P.、CECCOTTI, C.、DA, SETTIMO F.、PRIMOFIORE, G.、FRANZONE, J. S.、REB+
    DOI:——
    日期:——
查看更多